CLDI ▼ -3.1% - Calidi Biotherapeutics, Inc. $CLDI - Calidi Biotherapeutics Presented New CLD-401 Data and In Situ TCE Platform Advances at the ESMO Congress 2026, Including Highlighting the Potential of its RedTail Gene Medicine Platform to Turn Tumors into Localized TCE Biofactories 27-OCT-2026 08:00 AM ET